Patriot Scientific

...the messages of utter woe and capitulation likely indicate a bottom soon. I agree, owning this stock is tough to take. But I think everyone knew that revenue-wise, this was not going to be a great quarter. On top of that, it absorbed most of the legal costs relating to the settlement, the revenues for which will not appear until the April filing. A double-whammy. We already know Q3 will be much better, and this 10Q confirmed beyond a shadow of a doubt that the J's did purchase licenses as part of the settlement. Selling at or near the bottom is not usually conducive to wealth-building. I'll be looking to add a few around .45.

That said, Turley MUST get some forward-looking info. out to the investment community.